Drugs / Keluoxin Capsules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06660940 | Oct 2024 → Oct 2027 expected | diabetic kidney disease, diabetic retinopathy | Chinese PLA General Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Keluoxin Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06660940 ↗ |
| Route | Oral | “swallow with warm water after meals” NCT06660940 ↗ |